The JPM Q1 2024 MedTech Licensing and Venture report highlights the first quarter of 2024 and shows promising developments in the MedTech investment landscape. There are indications of a potential recovery and growth compared to previous years. Can we be so lucky?...
McDermott + Bull has successfully placed Tom Mock as the Director of Research and Development at NVMedTech. Tom will oversee the completion of one of the company’s main intravascular products, managing its design finalization, initiating GLP animal studies, and...
McDermott + Bull has successfully placed Mazi Kiani as Senior Vice President of Quality + Regulatory Affairs at Inari Medical. Mazi will be responsible for ensuring the highest standards of product quality and safety are achieved while navigating complex global...
McDermott + Bull Partner Ken Dropiewski interviews BioStar Capital’s Founder + Senior Managing Director Louis Cannon and Managing Director Alan Davis in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken, Louis, and Alan...
McDermott + Bull has successfully placed Yocely Schwab as Senior Director of Manufacturing at Inari Medical. Yocely will oversee large manufacturing teams while focusing on directing and optimizing production processes to ensure operational efficiencies. She will also...
McDermott + Bull has successfully placed Kris Krustangel as Vice President of Sales at Vertos Medical. In this pivotal role, Kris will drive the expansion of Vertos’s sales efforts and accelerate the commercial reach of the mild procedure, aiming to make it accessible...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
